Le Lézard
Classified in: Health
Subjects: MAV, FVT, CFG, MAT

/C O R R E C T I O N from Source -- Health Canada (HC)/


In the news release, Notice to the media - Health Canada officials will provide an update on the legalization and regulation of cannabis, issued 13-Jun-2019 by Health Canada (HC) over PR Newswire, we are advised by the company that the passcode number should read 7070598 rather than 4307946 as originally issued inadvertently. The complete, corrected release follows:

Notice to the media - Health Canada officials will provide an update on the legalization and regulation of cannabis

OTTAWA, June 13, 2019 /CNW/ - Health Canada officials will hold a media technical briefing regarding the next steps in the legalization and regulation of cannabis.

Officials will be available to answer questions from the media following their statements.

Date
June 14, 2019

Time
12:30 PM (EDT)

Location
Teleconference only:
Toll-free dial-in number: 1-866-206-0153
Pass code: 7070598

Notes for Media:
RSVP to [email protected] or (613) 957-2983 to receive a Technical Briefing Package

 

SOURCE Health Canada


These press releases may also interest you

at 16:05
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today...

at 16:05
Stevanato Group S.p.A. , a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the first...

at 16:05
Bruker Corporation today announced it will report first quarter 2024 financial results before market opening on Thursday, May 2, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current...

at 16:05
Gilead Sciences, Inc. announced today its first quarter 2024 results of operations. "Gilead delivered another strong quarter of revenue growth in the first quarter with 6% year-over-year growth in our base business driven by HIV, Oncology and...

at 16:05
DexCom, Inc. today reported its financial results as of and for the quarter ended March 31, 2024. First Quarter 2024 Financial Highlights: Revenue grew 24% year-over-year to $921.0 million on a reported basis and 25% year-over-year on an...

at 16:05
Ironwood Pharmaceuticals, Inc. today announced it will host its first quarter 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, May 9, 2024. Individuals interested in participating in the call should dial (888)...



News published on and distributed by: